Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Last updated: September 8, 2025
Sponsor: Third Wave Therapeutics
Overall Status: Completed

Phase

N/A

Condition

Inflammation

Acute Rhinitis

Nasal Obstruction

Treatment

Acoustic Resonance (Sound) Therapy

Clinical Study ID

NCT06773013
CP-008
  • Ages 12-21
  • All Genders

Study Summary

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pediatric subjects between the ages of 12 to 21 years

  • Present with symptoms of nasal congestion for 1 month or more prior to treatment

  • Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0to 3 scale at the time of screening

Exclusion

Exclusion Criteria:

  • Head, nasal or sinus surgery within 3 months

  • Sinus infection diagnosed within the last month, or rhinitis medicamentosa

  • Documented history of nasal polyposis or mass

  • Pregnancy

Study Design

Total Participants: 31
Treatment Group(s): 1
Primary Treatment: Acoustic Resonance (Sound) Therapy
Phase:
Study Start date:
January 09, 2025
Estimated Completion Date:
March 30, 2025

Connect with a study center

  • Crescendo MD

    Portola Valley 5384478, California 5332921 94028
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.